Recent Changes in Tuberculosis Guidelines: What’s New
for Ocular Tuberculosis
Volume 2 - Issue 1
Amber Kumar2, Priyanka1* and Mahesh Maheshwari3
-
Author Information
Open or Close
- 1 Department of Ophthalmology, AIIMS, Bhopal, India
- 2 Assistant Professor, Department of Pediatrics, AIIMS, Bhopal, India
- 3 Associate Professor, Department of Pediatrics, AIIMS, Bhopal, India
*Corresponding author:
Dr Priyanka, Department of Ophthalmology, AIIMS, Bhopal, India
Received: January 26, 2019; Published: February 01, 2019
DOI:
10.32474/TOOAJ.2018.02.000130
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Ocular TB can cause moderate to severe visual impairment in up to 40% of affected eyes. Delay in diagnosis and treatment can
result in chronic inflammation and loss of vision. The pathogenesis of ocular tuberculosis is still not clear, whether it result from a
direct mycobacterial infection or a hypersensitivity response to mycobacterium tuberculosis. The choroidal nodules likely link from
direct hematogenous infection while the vasculitis and choroiditis are probably the result of immune hypersensitivity. Prevalence
of tuberculosis as an etiology of uveitis range from 5- 10% in endemic areas. Tuberculous uveitis inevitably leads to blindness if
not properly diagnosed and treated. The aim of this paper is to review the presentation, diagnosis and management of tuberculous
uveitis and to highlight the recent changes in the tuberculosis guidelines. Indian extrapulmonary tuberculosis (EPTB) guidelines
were developed under the auspices of Central TB Division and Directorate of Health Services, Ministry of Health and Family Welfare,
Government of India in 2016, with the objective of providing guidance on uniform, evidence-informed practices for suspecting,
diagnosing and managing EPTB.
Keywords:ATT; Diagnosis; Ocular Tuberculosis; TST; Uveitis
Abstract|
Introduction|
Diagnosis|
Conclusion|
References|